BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu HHL, Rakisheva A, Ponnusamy A, Chinnadurai R. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity? World J Gastroenterol 2024; 30(2): 128-136 [PMID: 38312119 DOI: 10.3748/wjg.v30.i2.128]
URL: https://www.wjgnet.com/1948-5182/full/v30/i2/128.htm
Number Citing Articles
1
V. Rudyashko. Changes in urine properties in dogs with combined liver and kidney diseaseScientific Messenger of LNU of Veterinary Medicine and Biotechnologies 2025; 27(119): 203 doi: 10.32718/nvlvet11928
2
Karel Kostev, Jamschid Sedighi, Samuel Sossalla, Marcel Konrad, Mark Luedde. Both Alcoholic and Non-Alcoholic Liver Cirrhosis Are Associated with an Increased Risk of HF—A Cohort Study Including 75,558 PatientsJournal of Cardiovascular Development and Disease 2025; 12(8): 295 doi: 10.3390/jcdd12080295
3
Ramadan A. Saad, Mai Tarek, Howaida S. Ali, Wael M. Elayat, Abd El-Hamid A. Mohamed. Vitamin D3 Ameliorates BDL-Induced Hepatocardiac Abnormalities. Possible Role of IGF-1Journal of Evolutionary Biochemistry and Physiology 2025; 61(1): 327 doi: 10.1134/S0022093024600519
4
Lavinia Alice Bălăceanu, Cristiana Grigore, Beatrice Bălăceanu-Gurău, Cristian-Dorin Gurău, Ioana Valeria Grigorescu, Ion Dina. Paroxysmal Atrial Fibrillation in Liver Diseases: Epidemiology and Possible Pathophysiological MechanismsJournal of Clinical Medicine 2026; 15(3): 1156 doi: 10.3390/jcm15031156
5
Dae Gon Ryu, Fengxue Yu, Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. The Cardiomyocyte in Cirrhosis: Pathogenic Mechanisms Underlying Cirrhotic CardiomyopathyReviews in Cardiovascular Medicine 2024; 25(12) doi: 10.31083/j.rcm2512457
6
V. L. Korobka, Yu. V. Khoronko, R. V. Korobka, E. V. Kosovtsev, M. V. Malevanny, E. S. Pak, E. V. Tadieva. Transjugular intrahepatic portosystemic shunting in patients over 60 years with cirrhosis and comorbidities when liver transplantation is reasonably deniedAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2024; 29(3): 40 doi: 10.16931/31/1995-5464.2024-3-40-49
7
Jacopo BELFIORE, Michele CHECCHI, Niccolò CASTELLANI NICOLINI, Pietro BERTINI, Dmitri BEZINOVER, Lorenzo DE MARCHI, Giandomenico BIANCOFIORE. Transesophageal echocardiography monitoring for liver transplantation: where are we now?Minerva Anestesiologica 2025; 91(10) doi: 10.23736/S0375-9393.24.18483-0
8
Sheng-Hao Li, Lu Zhang, Hong-Juan Li, Ye Li, Yan-Min Zheng, Qing-Qing Wang. Left Ventricular Diastolic Dysfunction Increases the Risk of Medium-term Mortality in Patients with Cirrhotic AscitesRomanian Journal of Internal Medicine 2026; 64(1): 13 doi: 10.2478/rjim-2025-0022
9
Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Hongbo Du, Peng Zhang, Yongan Ye. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicineFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1381476
10
Jacob J. Gries, Bing Chen, Meena B. Bansal, Mario Rodriguez, Saleh A. Alqahtani, Paul N. Brennan, Chim C. Lang, W. H. Wilson Tang, Jeffrey V. Lazarus, Chayakrit Krittanawong. Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver diseaseCommunications Medicine 2025; 5(1) doi: 10.1038/s43856-025-00951-2
11
Lavinia Alice Bălăceanu, Cristiana Grigore, Ion Dina, Cristian-Dorin Gurău, Mara Mădălina Mihai, Beatrice Bălăceanu-Gurău. CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic ConsiderationsJournal of Clinical Medicine 2025; 14(12): 4152 doi: 10.3390/jcm14124152
12
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
13
John Nzobokela, Lweendo Muchaili, Alick Mwambungu, Sepiso K. Masenga, Annet Kirabo. Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndromeFrontiers in Cardiovascular Medicine 2025; 12 doi: 10.3389/fcvm.2025.1661563